Tongo M - Search Results

1

Characterization of HIV-1 gag and nef in Cameroon: further evidence of extreme diversity at the origin of the HIV-1 group M epidemic.

Tongo M, Martin DP, Zembe L, Mpoudi-Ngole E, Williamson C, Burgers WA. Tongo M, et al. Virol J. 2013 Jan 22;10:29. doi: 10.1186/1743-422X-10-29. Virol J. 2013. PMID: 23339631 Free PMC article.

2

Inaccurate diagnosis of HIV-1 group M and O is a key challenge for ongoing universal access to antiretroviral treatment and HIV prevention in Cameroon.

Aghokeng AF, Mpoudi-Ngole E, Dimodi H, Atem-Tambe A, Tongo M, Butel C, Delaporte E, Peeters M. Aghokeng AF, et al. Among authors: tongo m. PLoS One. 2009 Nov 6;4(11):e7702. doi: 10.1371/journal.pone.0007702. PLoS One. 2009. PMID: 19893738 Free PMC article.

3

WHO clinical criteria-based initiation of antiretroviral therapy: lessons from rural district hospitals in Cameroon with regard to 2009 revised WHO recommendations.

Kouanfack C, Laborde-Balen G, Aghokeng AF, Bourgeois A, Dontsop M, Mben JM, Kazé S, Mpoudi-Ngolé E, Koulla-Shiro S, Delaporte E, Laurent C; Stratall ANRS 12110/ESTHER Study Group. Kouanfack C, et al. Trop Med Int Health. 2010 May;15(5):580-3. doi: 10.1111/j.1365-3156.2010.02495.x. Epub 2010 Mar 1. Trop Med Int Health. 2010. PMID: 20214755 Free article. Clinical Trial.

4

Refined identification of neutralization-resistant HIV-1 CRF02_AG viruses.

Jacob RA, Abrahams F, Tongo M, Schomaker M, Roux P, Mpoudi Ngole E, Burgers WA, Dorfman JR. Jacob RA, et al. Among authors: tongo m. J Virol. 2012 Jul;86(14):7699-703. doi: 10.1128/JVI.00804-12. Epub 2012 May 9. J Virol. 2012. PMID: 22573859 Free PMC article.

5

Striking lack of T cell immunodominance in both a multiclade and monoclade HIV-1 epidemic: implications for vaccine development.

Tongo M, Zembe L, Ebong E, Roux S, Bekker LG, Williamson C, Mpoudi-Ngole E, Burgers WA. Tongo M, et al. Vaccine. 2014 Apr 25;32(20):2328-36. doi: 10.1016/j.vaccine.2014.02.063. Epub 2014 Mar 2. Vaccine. 2014. PMID: 24598726

6

Challenges in the design of a T cell vaccine in the context of HIV-1 diversity.

Tongo M, Burgers WA. Tongo M, et al. Viruses. 2014 Oct 23;6(10):3968-90. doi: 10.3390/v6103968. Viruses. 2014. PMID: 25341662 Free PMC article. Review.

7

Evaluating potential T-cell epitope peptides for detecting HIV-specific T cell responses in a highly diverse HIV-1 epidemic from Cameroon.

Tongo M, Riou C, Crunchant E, Müller TL, Strickland N, Mpoudi-Ngole E, Burgers WA. Tongo M, et al. AIDS. 2015 Mar 13;29(5):635-639. doi: 10.1097/QAD.0000000000000581. AIDS. 2015. PMID: 25715106 Free PMC article.

8

Phylogenetics of HIV-1 subtype G env: Greater complexity and older origins than previously reported.

Tongo M, Essomba RG, Nindo F, Abrahams F, Nanfack AJ, Fokam J, Takou D, Torimiro JN, Mpoudi-Ngole E, Burgers WA, Martin DP, Dorfman JR. Tongo M, et al. Infect Genet Evol. 2015 Oct;35:9-18. doi: 10.1016/j.meegid.2015.07.017. Epub 2015 Jul 17. Infect Genet Evol. 2015. PMID: 26190450

9

Near full-length HIV type 1M genomic sequences from Cameroon : Evidence of early diverging under-sampled lineages in the country.

Tongo M, Dorfman JR, Abrahams MR, Mpoudi-Ngole E, Burgers WA, Martin DP. Tongo M, et al. Evol Med Public Health. 2015 Sep 9;2015(1):254-65. doi: 10.1093/emph/eov022. Evol Med Public Health. 2015. PMID: 26354000 Free PMC article.

10

High Degree of HIV-1 Group M (HIV-1M) Genetic Diversity within Circulating Recombinant Forms: Insight into the Early Events of HIV-1M Evolution.

Tongo M, Dorfman JR, Martin DP. Tongo M, et al. J Virol. 2015 Dec 9;90(5):2221-9. doi: 10.1128/JVI.02302-15. J Virol. 2015. PMID: 26656688 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters